Cholestatic liver diseases: Slow progress in understanding and treating slowly progressive disorders

Scandinavian Journal of Gastroenterology, Supplement

Volumn 35, Issue 232, 2000, Pages 86-92

  Vleggaar, F P ^b   Van Ooteghem, N A M ^b   Van Buuren, H R ^b   Van Berge, G P ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NONE

Author keywords

BRIC; PFIC; Primary biliary cirrhosis; Primary sclerosing cholangitis

Indexed keywords

BILE DUCT OBSTRUCTION; BILE FLOW; CHRONIC LIVER DISEASE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; FAMILIAL DISEASE; GENETIC ANALYSIS; HUMAN; INTRAHEPATIC BILE DUCT; PATHOPHYSIOLOGY; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; RECURRENT DISEASE; BIOSYNTHESIS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; GENETIC MARKER; GENETIC PREDISPOSITION; GENETICS; INTRAHEPATIC CHOLESTASIS; LIVER; METABOLISM; MUTATION; PATHOLOGY; PREVALENCE; PROGNOSIS; REVIEW; SCLEROSING CHOLANGITIS;

BILE ACID;

BILE ACIDS AND SALTS; CHOLANGITIS, SCLEROSING; CHOLESTASIS, INTRAHEPATIC; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIVER; MUTATION; PREVALENCE; PROGNOSIS;

EID: 0034351814     PISSN: 00855928     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Desmet VJ. Vanishing bile duct disorders. In: Boyer JL, Ockner RK, editors. Progress in liver disease. Philadelphia: W. B. Saunders; 1992. p. 89-121.
2. Neuberger J. Primary biliary cirrhosis. Lancet 1997;350:875-9.
3. Triger DR. Primary biliary cirrhosis: an epidemiological study. Br Med J 1980;281:772-5.
4. Triger DR, Berg PA, Rodes J. Epidemiology of primary biliary cirrhosis. Liver 1984;4:195-200.
5. Myszor M, James OF. The epidemiology of primary biliary cirrhosis in north-east England: an increasingly common disease? Q J Med 1990;75:377-85.
6. Danielsson A, Boqvist L, Uddenfeldt P. Epidemiology of primary biliary cirrhosis in a defined rural population in the northern part of Sweden. Hepatology 1990;11:458-64.
7. Kingham JG, Parker DR. The association between primary biliary cirrhosis and coeliac disease: a study of relative prevalences. Gut 1998;42:120-2.
8. James OF, Bhopal R, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390-4.
9. Watson RG, Angus PW, Dewar M, Goss B, Sewell RB, Smallwood RA, et al. Low prevalence of primary biliary cirrhosis in Victoria, Australia. Gut 1995;36:927-30.
10. Dickson ER, Fleming TR, Wiesner RH, Baldus WP, Fleming CR, Ludwig J, et al. Trial of penicillamine in advanced primary biliary cirrhosis. N Engl J Med 1985;312:1011-5.
11. McCormick PA, Scott F, Epstein O, Burroughs AK, Scheuer PJ, McIntyre N. Thalidomide as therapy for primary biliary cirrhosis: a double-blind placebo controlled pilot study. J Hepatol 1994;21:496-9.
12. Van Buuren HR. The results of a randomized double blind controlled trial evaluating malotilate in primary biliary cirrhosis. A European multicentre study group. J Hepatol 1993;17:227-35.
13. Lombard M, Portmann B, Neuberger J, Williams R, Tygstrup N, Ranek L, et al. Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology 1993;104:519-26.
14. Hendrickse MT, Rigney E, Giaffer MH, Soomro I, Triger DR, Underwood JC, et al. Low-dose methotrexate is ineffective in primary biliary cirrhosis: long-term results of a placebo-controlled trial. Gastroenterology 1999;117:400-7.
15. Battezzati PM, Podda M, Bianchi FB, Naccarato R, Orlandi F, Surrenti C, et al. Ursodeoxycholic acid for symptomatic primary biliary cirrhosis. Preliminary analysis of a double-blind multi-center trial. Italian Multicenter Group for the Study of UDCA in PBC. J Hepatol 1993;17:332-8.
16. Leuschner U, Fischer H, Kurtz W, Guldutuna S, Hubner K, Hellstem A, et al. Ursodeoxycholic acid in primary biliary cirrhosis: results of a controlled double-blind trial. Gastroenterology 1989;97:1268-74.
17. Turner IB, Myszor M, Mitchison HC, Bennett MK, Burt AD, James OF. A two year controlled trial examining the effectiveness of Ursodeoxycholic acid in primary biliary cirrhosis. J Gastroenterol Hepatol 1994;9:162-8.
18. Heathcote EJ, Cauch-Dudek K, Walker V, Bailey RJ, Blendis LM, Ghent CN, et al. The Canadian Multicenter Double-blind Randomized Controlled Trial of Ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1994;19:1149-56.
19. Poupon RE, Baikau B, Eschwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991; 324:1548-54.
20. Combes B, Carithers R Jr, Maddrey WC, Lin D, McDonald MF, Wheeler DE, et al. A randomized, double-blind, placebo-controlled trial of Ursodeoxycholic acid in primary biliary cirrhosis. Hepatology 1995;22:759-66.
21. Lindor KD, Dickson ER, Baldus WP, Jorgensen RA, Ludwig J, Murtaugh PA, et al. Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology 1994;106:1284-90.
22. Eriksson LS, Olsson R, Glauman H, Prytz H, Befrits R, Ryden BO, et al. Ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. A Swedish multicentre, double-blind, randomized controlled study. Scand J Gastroenterol 1997;32: 179-86.